IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
Metabolic Syndrome Risk Doubles With Schizophrenia Drug
From:
Alison Hymes <[log in to unmask]>
Reply To:
[log in to unmask]
Date:
Thu, 13 Jul 2006 10:17:43 -0400
Content-Type:
text/plain
Parts/Attachments:
text/plain (11 lines) 
http://www.medpagetoday.com/Psychiatry/GeneralPsychiatry/tb/3708

Metabolic Syndrome Risk Doubles With Schizophrenia Drug

In a study evaluating patients with schizophrenia or schizoaffective
disorder taking Clozaril, more than half had metabolic syndrome symptoms,
compared with only one-fifth of matched controls, said psychiatrist J.
Steven Lamberti, M.D., of the University of Rochester (N.Y.) Medical Center.

www.peoplewho.org

ATOM RSS1 RSS2